
Dapafree 5mg Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dapafree 5mg Tablet
Glimepiride 5mg tablets are indicated, either independently or in conjunction with other therapies, for managing type 2 diabetes. This medication regulates elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Glimepiride 5mg may be administered with or without food, but consistent daily timing is recommended. Dosage is determined by your physician and should not be altered without their explicit consent; cessation may lead to hyperglycemia and potentially severe consequences such as renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan encompassing dietary adjustments, regular physical activity, and weight management, all under medical supervision. Commonly reported adverse reactions include vaginal candidiasis, nasopharyngitis, and urinary tract infections; fluid loss may also occur, necessitating ample hydration to avoid dehydration. Practicing diligent hygiene can help reduce the incidence of genital fungal infections. Prior to commencing treatment, patients with pre-existing renal or hepatic dysfunction, urinary tract infections, or those using diuretics should inform their doctor. Pregnant or lactating individuals require medical consultation before initiating treatment. Excessive alcohol consumption should be avoided due to the potential for increased adverse effects. Regular blood glucose monitoring is essential throughout treatment.
Uses of Dapafree 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dapafree 5mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapafree 5mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dapafree 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapafree 5mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapafree 5mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Dapafree 5mg Tablet works:
Dapafree 5mg tablets help manage diabetes by facilitating the excretion of excess glucose via the urinary tract.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dapafree 5mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dapafree 5mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is recommended.
Breast feedingCONSULT YOUR DOCTOR
Using Dapafree 5mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dapafree 5mg tablets is potentially hazardous for individuals with impaired kidney function and should be avoided. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
The 5mg Dapafree tablet presents no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Dapafree 5mg Tablet :
Should you forget a Dapafree 5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapafree 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
